Home  »  Stock   »  GreenLight Biosciences Holdings Inc. (GRNA) Price ...

GreenLight Biosciences Holdings Inc. (GRNA) Price Performance: Is It Undervalued or Overvalued?

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -83.36% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -83.64%. Over the past 30 days, the price of GRNA has leaped by -38.44%. And in the last five days, it has surged by 1.39%.

The stock of GreenLight Biosciences Holdings (GRNA) is currently priced at $0.20. In the last session, the stock climbed significantly, topping out at $0.2111 after opening at $0.18. The day’s lowest price was $0.18 before the stock closed at $0.18.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


GreenLight Biosciences Holdings experienced a rather shaky stock market performance. The highest value in the past year was recorded at $8.34 on 06/03/22 and the lowest value was $0.18 on 05/24/23.

52-week price history of GRNA Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. GreenLight Biosciences Holdings’s current trading price is -97.65% away from its 52-week high, while its distance from the 52-week low is 11.03%. The stock’s price range during this period has varied between$0.18 and $8.34. The GreenLight Biosciences Holdings’s shares, which operate in the Healthcare, saw a trading volume of around 0.78 million for the day, a figure considerably higher than their average daily volume of 0.4 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

GreenLight Biosciences Holdings (GRNA) has experienced a quarterly decline of -65.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 30.22M and boasts a workforce of 262 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5939, with a change in price of -0.9837. Similarly, GreenLight Biosciences Holdings recorded 336,683 in trading volume during the last 100 days, posting a change of -83.36%.

GRNA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GRNA stands at 1.13. Similarly, the long-term debt-to-equity ratio is also 0.50.

GRNA Stock Stochastic Average

As of today, GreenLight Biosciences Holdings’s raw stochastic average for the last 50 days stands at 4.84%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 13.15%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 5.48% and 3.49%, respectively.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts